The kinetics of the regional cerebral uptake of ["C] 3-0-methyl-o-glucose (["C1MeG), a competitive in hibitor of o-glucose transport, have been studied in normal human subjects and patients with cerebral tu mours using positron emission tomography (PET), Con comitant measurement of regional cerebral blood volume and blood flow enabled corrections for the contribution of intravascular tracer signal in PET scans to be carried out and regional unidirectional cerebral ["C1MeG extrac tions to be determined, A three-compartment model con taining an arterial plasma and two cerebral compartments was required to produce satisfactory fits to experimental regional cerebral [ l lCJMeG uptake data. Under fasting, resting conditions, normal controls had mean unidirec tional whole-brain, cortical, and white matter ["C1MeG extractions of 14, 13, and 17%, respectively. Mean values of k, and k2, first-order rate constants describing forward and back transport, respectively, of tracer into the first cerebral compartment, were similar for ["C1 MeG and ['8F] 2-fluoro-2-deoxy-o-glucose ( , 8FDG), a second com-Studies on intact dog and rat brain, and also on isolated cerebral rat brain capillaries, have shown that D-glucose transport across the blood-brain barrier (BBB) is a passive facilitated process (Crone, 1965; Betz et aI., 1973 Betz et aI., , 1979 Pard ridge and Oldendorf, 1975). 3-0-Methyl-D-glucose (MeG) and 2-deoxY-D-glucose (2-DG) have both been shown to
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be competitive inhibitors of such D-glucose trans port (Bidder, 1968; Pardridge and Oldendorf, 1975; Betz et aI. , 1979) . 2-DG can be phosphorylated by hexokinase (Sokoloff et aI. , 1977) , and models have been developed for determining regional cerebral glucose utilization in humans using [18F]2-fluoro-2-deoxY-D-glucose ( l 8FDG) and positron emission to mography (PET) (Phelps et aI. , 1979a; Reivich et aI. , 1979 Reivich et aI. , , 1985 Huang et aI. , 1980; Brooks, 1982; Rhodes et aI. , 1983) .
Until recently, based on observations in the rat (Csaky and Wilson, 1956) and in frog muscle (Nara hara and O zand, 1963) , it has been assumed that MeG is not phosphorylated by hexokinase, acting purely as a nonmetabolized transport analogue of D-glucose. In addition, the affinity of MeG and D-glucose for the D-hexose carrier is very similar in rat brain (Pardridge and Oldendorf, 1975) . As a consequence, [IIC]MeG has been advocated as a suitable tracer for studying glucose transport across the human BBB using PET (Vyska et aI., 1981; Gjedde, 1982) . While in theory cerebral 18FDG could also be used to study hexose transport across the BBB, such uptake reflects both transport of free FDG into brain tissue and FDG phosphoryla tion. Recently, however, Gatley et ai. (1984) have shown that intact myocardium is capable of phos phorylating MeG.
The purpose of this study was first to examine [lIC]MeG cerebral uptake kinetics in humans to see whether these could be adequately described in terms of a two-compartment model, as has been previously suggested (Vyska et aI., 1981; Gjedde, 1982; Gjedde et aI., 1985) . Second it was desired to study [IIC] MeG uptake by gliomas, as tissue cul ture studies have shown increased levels of MeG and 2-DG transport into isolated tumour cells (Ha tanaka et aI., 1970; Venuta and Rubin, 1973; Weber 1973) . Third it was desired to study the effect of cerebral tumours on [llC]MeG transport into con tralateral cortical tissue. In this way it was hoped to gain insight into the control of D-glucose transport across the BBB.
METHODS

Patient selection
Seven normal normotensive subjects, ranging in age from 23 to 65 years and with no past history of neurolog ical problems, were studied. Four were selected to deter mine regional cerebral [IIClMeG uptake kinetics and three to determine regional cerebral 18FDG uptake ki netics. Seven patients with gliomas were selected for studying regional cerebral [IIClMeG uptake. Patient de tails are given in Table I . All subjects were studied under E, enhancing, and N, nonenhancing, on computed tomog raphy brain scan.
resting conditions with their eyes closed, having fasted for 4-8 h prior to PET scanning. Their arterial plasma o-glucose levels remained steady between 4 and 6 mM throughout PET.
Informed consent was obtained from all subjects prior to PET scanning. This project was approved by the Ethics Committee of the Royal Postgraduate Medical School, Hammersmith Hospital (London, U.K.). Permis sion to administer radioactive isotopes was granted by the Administration of Radioactive Substances Advisory Committee (U.K.).
Tracer preparation
[IIClMeG was prepared using a modification of the method of Kloster et al. (1981) (D. R. Turton et aI., in preparation) . The sodium salt of commercially available diacetone-D-glucose was prepared by reacting this sub strate with sodium hydride in diethylether. This salt was methylated in the 3-position with IICH,I and then hydro lysed to [IIClMeG with HCI. Synthes is time, including purification by high pressure liquid chromatography, was �50 min. Yields of up to 12.5 mCi were obtained in injec table solution. The absence of any impurities after chro matography was confirmed by preparing cold MeG using the same synthetic route and comparing its proton nu clear magnetic resonance spectrum with that of commer cially available compound. 18FDG was prepared using the method of Ido et al. (1977 ) , yields of up to 6 mCi being obtained in injectable solution.
Scanning procedures
Normal subjects were scanned at an axial level of 6.5 cm above the orbitomeatal line (OM + 6.5 cm) for [IIClMeG uptake studies, and at a level of OM + 4.5 cm for 18FDG uptake studies. Patients with gliomas were scanned at the axial tomographic level of the tumour as defined by the computed tomography brain scan. All subjects had an initial transmission scan performed using an external 68Ge ring source so that tissue attenuation of 51 1 ke V "I-radiation could be determined (Frackowiak et ai., 1980) . Regional CBF (rCBF) was then determined using steady-state inhalation of CI502 (Frackowiak et ai., 1980) . After cerebral 150 activity had cleared, either [IIClMeG or 18FDG was administered by intravenous in fusion while serial PET scanning at a fixed axial tomo graphic level was performed. In the case of [IIClMeG, tracer was infused at a steady rate over 4 min using a Harvard pump. At the onset of the infusion, PET scan ning was started, \0 120-s and then 4 300-s scans being performed. Scans typically contained between 50,000 and 80,000 true coincident events. During PET scanning, ar terial blood samples were withdrawn, initially at 30-s in tervals, and arterial plasma and whole-blood [IIClMeG levels were measured in a well counter cross-calibrated against the PET scanner. Plasma was separated from red cells in such arterial blood samples by centrifugation of 30-45 s prior to well counting.
In the case of 18FDG, tracer was infused intravenously over 2 min while five serial 60-s PET scans and then six 300-s scans followed by one 600-s scan were performed. Arterial plasma and whole-blood 18F levels were counted during scanning, initially at 20-s intervals. Finally, regional cerebral blood volume (rCBV) was estimated following IlCO inhalation (Lammertsma et aI., 1983) . Assumed values of both 0.85 and 0.69 were used for r, the cerebral small vessel-to-peripheral large vessel haematocrit ratio, in rCBV calculations (Phelps et aI., 1979h; Lammertsma et aI., 1984) .
Data analysis
Elliptical whole-brain and hemisphere regions of in terest were defined from the rCBF image, stored, and overlaid on the rCBV and ["CJMeG or '8FDG images. Typically whole-brain regions of interest contained >2,000 2.5 x 2.5-mm pixels. Cortical or hemicortical function was sampled using the rCBF image to define a cortical plot as previously described (Brooks et aI., 1984) . White matter function in scans at a level of OM + 6.5 cm was sampled using four I-cm-radius regions of in terest positioned in the centrum semiovale of the rCBF image as previously described (Frackowiak et aI., 1980) . Serial ["C]MeG and '8FDG scans were corrected for the contribution of intravascular tracer signal using the mea sured rCBV data and arterial tracer input curve.
Cerebral ["CJMeG and 'RFDG uptake kinetics were fitted to two-and three-compartment models (see Fig. I) using a modification of the BLD FIXK fitting routine supplied by Dr. R. Carson of the University of California at Los Angeles (Huang et aI., 1980; Carson et aI., 1981) .
Tracer model
[ I l C]MeG and 18FDG uptake by cerebral tissue both can be described in terms of a three-compartment model (Fig. I) . The first compartment represents arterial plasma, while in the case of FDG the first and second cerebral compartments represent free and phosphory lated tracer, respectively (Phelps et aI., 1979a) . In the case of ["C]MeG, the two cerebral compartments may represent either free and phosphorylated tracer or a main and a subcompartment for free tracer. For a substrate such as D-glucose, which is transported by a carrier mechanism, cerebral uptake is described by the Mi chaelis-Menten equation:
where v is the rate of influx of the substrate, V max the maximal influx rate, Km the half-saturation substrate concentration, and [S] the actual substrate concentration. If a tracer is a competitive inhibitor of such a carrier system, the rate of tracer uptake v* is given by (Mahler and Cordes, 1966) :
(2) where V;;',ax and K;' are the Michaelis-Menten tracer pa rameters, [S*] the plasma tracer concentration, and Ca the steady-state arterial D-glucose level.
This equation neglects free diffusion of tracer across the BBB. If this is considered, the permeability-surface area product (PS), for influx of free tracer into cerebral tissue is given by
In normal rat brain, kd has been estimated to contribute J Cereb Blood Flow Metab, Vol. 6, No.2, 1986 � I % toward the value of (PS), (Oldendorf, 1970) . k" the influx constant for free hexose across the BBB in Fig. 1 , can be related to the (PS), product by (Crone, 1963) ( 5) where F is solvent flow. In a similar manner, k2' k3' and k4 can be related to Michaelis-Menten parameters, k2 being a function of free intracerebral D-glucose levels. k3 and k4 are independent of rCBF but k, and k2 are rCBF dependent. Since for FDG and MeG under fasting, resting conditions, (PS)I is 20-25% of F; from Eq. 5,
Consequently, k, under these conditions is approximately a first-order influx constant. A unidirectional hexose extraction fraction E, can be related to k" the free hexose influx constant, by
Independent measurement of k, and rCBF enables the re gional unidirectional tracer extraction fraction E, to be determined, Figure 2 shows serial PET images of cerebral [IIC]MeG uptake in a normal subject at OM + 6.5 cm. Figure 3 shows the corresponding arterial plasma [ ll C]MeG input curve, and the fitted curve to the experimental whole-brain [ ll C]MeG uptake data, in this subject. It can be seen in Fig. 2 that initially [ l IC]MeG is distributed according to rCBF, but gradually it becomes uniformly distributed throughout brain tissue.
RESULTS
The relative accuracy of the fits obtained using a two-or a three-compartment model to describe whole-brain [ ll C]MeG uptake in a normal subject is shown in Table 2 . From a comparison of F values for the fits, significantly improved fits at a 5% level were obtained using a three-compartment model. While these three-compartment fits were sensitive to changes in k3' they were insensitive to changes in k4 and so k4 could not be accurately determined. Little change in the fitted values of kl' k2' and k3 resulted when k4 was fixed at values ranging from zero to the value of k3 ( Table 2 ). It is known that when MeG is administered intravenously, it is vir tually fully recovered from urine 24 h later (Csaky and Wilson, 1956) . As a consequence, k4 cannot be zero and was arbitrarily set equal to k3 in subse quent fitting procedures.
Cerebral regions of interest contain an intravas cular compartment that contributes toward the overall tracer signal. Failing to correct for this in- travascular tracer signal resulted in a significantly less accurate fit to experimental whole-brain lJ IC]MeG uptake data ( Table 3 ). In calculating rCBV using Ilca inhalation, a value has to be as sumed for r, the regional cerebral small vessel-to peripheral large vessel haematocrit ration (Phelps et aI., 1979h) . Conventionally r values of 0.85 have been used (Phelps et aI. , 1979h) , but a recent study has measured a mean whole-brain value of 0.69 for r (Lammertsma et aI., 1984) . Table 3 shows that the most accurate fits to the cerebral [IIC]MeG uptake data were obtained when a value of 0.69 was as sumed for r in rCBV calculations, though statisti cally the fit obtained using an r value of 0.85 was not significantly less accurate. Table 4 summarizes the individual and mean fitted values of kj, k2' and k3 for regional cerebral [ II C]MeG uptake in four normal subjects. Indi vidual normal values of regional cerebral [IIC]MeG extraction are portrayed as a dot diagram in Fig. 4 . Mean values of cortical and white matter [IIC]MeG extraction were found to be similar, 13 and 17% re spectively.
In Table 5 the individual and mean fitted values of kj, k2' k3, and k4 for regional cerebral 18FDG up take in three normal subjects are summarized. Mean fitted cortical FDG k, and kz values were of the same order of magnitude as those found for [IIC]MeG, but the k/kz ratios were consistently higher for FDG. The mean cortical k3 value fitted for FDG was 20 times higher than that fitted for ["C]MeG. Table 6 summarizes the mean fitted rate con stants for regional cerebral [IIC]MeG uptake by seven patients with gliomas. The individual glioma and contralateral cortical l"C]MeG extractions are also portrayed as a dot diagram in Fig. 4 . Glioma traction was calculated using regional cerebral whole-blood flow values, as measured using the C'50Z steady-state method for solvent flow in Eq. 7. Such rCBF values reflect the regional cerebral uptake of Hz'50 from whole blood (Frackowiak et aI., [980) . Our own observations suggest that both Hz'50 and ["ClMeG equilibrate within seconds be tween red cells and plasma with a similar whole blood volume of distribution of �85%. It would therefore seem reasonable to use whole-blood rCBF values measured via steady-state inhalation of C'502 in Eqs. 5 and 7.
Regional cerebral plasma flow (Fp) is related to regional cerebral whole-blood flow (rCBF) by
where h is the systemic haematocrit and r the ratio of cerebral small vessel to systemic large vessel haematocrit. For an h value of 0.4 and r value of 0.69 (Lammertsma et aI., [984) , Fp is 72% of rCBF. The use of Fp rather than rCBF in Eq. 7 will lead to 30-40% higher E, values.
Our value of 14% for the mean whole-brain uni directional [I I C]MeG extraction fraction in humans is in good agreement with the value of 14% found for o-glucose by Hertz et al. (198 1) using an indi cator dilution technique. It is, however, a little lower than the 22% extraction observed for MeG in rat brain (Pardridge and Oldendorf, 1975) . From ar teriovenous o-glucose differences, the net steady state cerebral o-glucose extraction (i.e., o-glucose influx minus o-glucose efflux) under fasting, resting conditions can be calculated to be 10% in humans (Siesj6, 1978) . In rat brain, o-glucose and MeG have been shown to have similar Km values of 9 and 10 mM, respectively (Pardridge and Oldendorf, 1975 Three-compartment model, k, = k4' r = 0.69, mean fasting plasma glucose = 4. 4 ± 0.4 mM. rCBF, regional CBF; rCBV, regional cerebral blood volume.
bined with the figure of 10% for the net bidirec tional steady-state extraction measured for D-glu cose, suggests that roughly 30-40% of the D-glu cose passively transported into cerebral tissue is passively transported unmetabolized back into ar terial plasma. : ripheral cortical gray and central white matter were similar, 13 and 17%, respectively. This finding is in line with studies on D-glucose transport into rat brain where D-glucose K m values were shown to be similar for gray and white matter . An equivalent situation exists for regional cerebral oxygen extraction, cortical gray and central white matter both extracting roughly 40% of the arterial oxygen supply under steady state conditions (Lammertsma et aI., 1983) . Brain tissue appears to regulate its regional supply of ox ygen and glucose according to its metabolic re quirements for these nutrients via rCBF changes, while keeping regional oxygen and glucose extrac tion fractions uniform. The mean k l values for cortical uptake of [IIC]MeG and 1 8FDG are seen to be similar (0.06 1 and 0.068, respectively) (Tables 4 and 5). This sug gests that k l indeed represents [ lI C]MeG transport into metabolically active cerebral tissue. V max has been shown in rat brain to be the same for 2-DG, MeG, and D-glucose, these hexoses all using the same D-glucose carrier (Pard ridge and Oldendorf, 1975 Mean k/k2: whole brain. 0.81: cortex. 0.80 r = 0.69. mean fasting plasma glucose = 4.6 ± 0.5 mM. rCBF. regional CBF: rCBV. regional cerebral blood volume.
From rat studies, whole-brain KmMeGIKmDG is 0.6 (Pard ridge and OldendorL 1975). Our results yielded a cortical klMeGlk/DG ratio of 0.9, sug gesting that FDG may be bound less tightly than 2-DG by the BBB hexose carrier.
The mean whole-brain k/k2 values were 0.38 for [I l C]MeG and 0.81 for 18FDG. Similar kllk2 values for 18FDG have been reported by Huang et al. (1980) and Reivich et al. (1985) . k l and k2 are func tions of the BBB hexose carrier V* max and K�, for tracer influx and efflux, respectively (see Eqs. 4 and 5). For a symmetrical carrier where K�� (influx) = K� (efflux), k/k2 would be expected to be sim ilar for all o-hexoses transported. The variation in kllk2 ratios between [11C]MeG and 18FDG implies that the influx and efflux Km values are not iden tical for D-hexoses and that the D-hexose carrier is in fact asymmetrical.
When applied to cerebral 18FDG uptake kinetics, the k3 in our three-compartment model represents phosphorylation of 18FDG to FDG-6-phosphate (Phelps, et aI., 1979a) . It has been assumed until recently that MeG is a nonmetabolized transport analogue of o-glucose with a k3 and a k4 value of zero (Vyska et aI., 1981; Gjedde, 1982) . This as sumption was based on animal studies (Csaky and Wilson, 1956; Narahara and O zand, 1963) which showed that intravenous administration of MeG to rats led to a 95% recovery of unaltered MeG in the urine, and that frog muscle homogenates failed to phosphorylate MeG. Gatley et al. (1984) , however, have shown that intact myocardium is capable of phosphorylating MeG. We were unable to fit cerebral [IIC]MeG uptake kinetics to a two-compartment model satisfactorily (see Table 2 ). that is, a model describing tracer up take in terms of BBB transport alone. Figure 5 shows the individual cerebral [IIC]MeG uptake data points of the four normal controls combined as a Gjedde plot (Gjedde, 1982) . This plot is linear if a TABLE 6. Mean k valueS/I}/" regional cerehral /" Cj3-0-methyl-D-glucose uptake inllormal subjects and glioma patients two-compartment model adequately describes ce rebral uptake of the tracer. Figure 5 shows that this plot is nonlinear for [lIC]MeG, demonstrating the presence of multiple cerebral compartments for this tracer. Table 4 ). This suggests that k3 either repre sents transport of free tracer into a lipid subcom partment, or reflects slower equilibration of [lIC]MeG between plasma and white matter as compared with gray matter, and does not represent tracer phosphorylation.
Our values of k l and k2 for 18FDG cerebral uptake are lower than previously published values, while our k3 and k4 values are higher (see Reivich et aI., 1985) . Most previous studies did not correct at all for the presence of intravascular 18FDG signal in cerebral regions of interest when computing their k values, while Phelps et al. (1979a) and Huang et al. (1980) probably undercorrected for this factor. As a consequence, previously published kl and k2 values for cerebral accumulation of 18FDG are likely to have been overestimations, which in turn led to re ciprocal underestimations of k3 and k4 values. Pardridge and Oldendorf (1975) have published a kl value of 0. 12 min -I for MeG uptake by rat brain, a value twice that of our measured value of 0.050 min-I for human brain. kl is, however, a function of CBF, and CBF in rats is also roughly twice that in humans (Siesj6 1978) . Their estimated cerebral volume of distribution Vd for MeG in rats ranged from 0.3 1 to 0.41. As Vd equals kl/(k2 + k3) (Gjedde, 1982) , the Vd for [IIC]MeG in our studies can be calculated to be 0.35, in good agreement with that of these workers. As k3 � kz for MeG, Vd is approximately equal to k l lk2. Pardridge and 01dendorf's Vd values of 0.3 1-0.41 for MeG in rat brain are in agreement with our mean whole-brain k l lk2 value of 0.38 for [lIC]MeG. Glioma [IIC]MeG extractions ranged from normal to twice-normal levels ( Table 6 ). The PET approach for measuring [IIC]MeG uptake in our studies is incapable of distinguishing between in creased tracer uptake due to increased free diffu sion, kd' and increased uptake due to increased fa cilitated transport. Increased MeG and 2-DG influx into transformed tumour cells has been docu mented in studies using tissue cultures. Hatanaka et al. (1970) have shown that mouse cells, when transformed with murine sarcoma virus, have an increased V max and decreased Km for 2-DG influx. Chick embryo fibroblasts transformed with Rous sarcoma virus show both an increased influx and efflux of MeG, attributable to increases in V max for this tracer (Venuta and Rubin, 1973; Weber, 1973) . This increased transport of o-glucose analogues FIG. 5. Individual whole-brain ["C]3-0methyl-D-gi ucose ([ " C]MeG) uptake data of the four normal subjects com bined shown as a Gjedde plot (Gjedde, 1982) . The nonlinearity of this plot con firms the existence of more than one cerebral compartment for this tracer. Ct, whole-brain [ " C]MeG activity at time t; Cp, plasma ["C]MeG activity at time t.
into cultured tumour cells parallels the increased level of aerobic glycolysis that has been docu mented in both animal and human tumour studies (Warburg, 1956; Sweeney et aI. , 1963; Weber, 1977; Weinhouse, 1982; Rhodes et aI. , 1983) . It is likely that where increased tumour extraction of [IIC]MeG was observed in our studies, both in creased tracer free diffusion and facilitated trans port were occurring. No significant inverse correla tion between tumour [11C]MeG extraction and tu mour blood flow was found, and so the observed rise in mean tumour [IIC]MeG extraction is likely to be a primary increase, rather than a secondary response to low tumour blood flow.
Mean blood flow and [11C]MeG k l and k2 values were all significantly depressed in the contralateral cortex of glioma patients ( Table 6) . It has been shown that the contralateral cortical oxygen metab olism of untreated patients with brain tumours is significantly depressed compared with that of normal controls (Beaney et aI. , 1985) . It is therefore not surprising that contralateral cortical glucose transport is depressed in such patients, as this probably reflects a decreased level of cortical glu cose metabolism.
In summary, use of a three-compartment model to describe [IIC]MeG cerebral uptake in human brain give unidirectional tracer extraction fractions and tracer volumes of distribution in reasonable agreement with those obtained for MeG in animal studies. Using such a model, normal or increased levels of glucose transport into gliomas were found, as predicted from previous studies on MeG trans port into isolated tumour cells prepared in tissue culture. Patients with cerebral tumours had a signif icantly depressed level of contralateral cortical [ 11 C]MeG transport.
